Objective: Studies in pulmonary arteries (PA) of patients with chronic obstructive pulmonary disease (COPD) suggest that bone marrowderived endothelial progenitor cells (CD133 + ) may infiltrate the intima and differentiate into smooth muscle cells (SMC). This study aimed to evaluate the plasticity of CD133 + cells to differentiate into SMC and endothelial cells (EC) in both cell culture and human isolated PA. Methods: Plasticity of granulocyte-colony stimulator factor (G-CSF)-mobilized peripheral blood CD133 + cells was assessed in co-cultures with primary lines of human PA endothelial cells (PAEC) or SMC (PASMC) and in isolated human PA. We also evaluated if the phenotype of differentiated progenitor cells was acquired by fusion or differentiation.
Introduction
Patients with COPD show striking changes in pulmonary muscular arteries and precapillary vessels that explain the presence of pulmonary hypertension [1, 2] . The hallmark of pulmonary vascular derangement in this group of patients is the thickening of the intimal layer due to smooth muscle-like cell proliferation. The etiology of vascular changes at the initial stage of the disease remains still uncertain. The most plausible hypotheses about the origin of intimal cells include: a) transdifferentiation of endothelial cells into smooth muscle cells [3, 4] ; b) differentiation of adventitial fibroblasts into myofibroblasts and migration into the intimal layer throughout the media [5, 6] ; and, c) recruitment of circulating bone-marrow stem cells throughout endothelium, migration towards the intima and differentiation into smooth muscle cells [7] . The latter is specially suggestive because it does not exclude any of the aforementioned hypotheses since the differentiation process of stem cells may be sensitive to different microenvironments. Moreover, it provides a simple explanation about the degree of cell maturity, proliferative capacity and regional heterogeneity within cells observed in both the media and intimal layers along the vascular tree [8] [9] [10] .
The identification of stem cells playing a role in vascular repair remains unresolved. There is consensus on the existence of a circulating endothelial precursor with properties similar to those of embryonic angioblasts [11] . This precursor, with a bone-marrow origin, can be identified by a characteristic surface phenotype positive for CD34, CD133, and VEGF receptor-2 (VEGFR-2) [12] and can differentiate to endothelial cell in vitro [13] . Recent studies have suggested that CD133 + cells may possess differentiation potential, both in vitro and in vivo, not limited to endothelial lineage [14] , although it is not clear whether this apparent plasticity could be attributed in all tissues to transdifferentiation [14] or cell fusion processes [15] . Although there is not doubt that these cells may play a role in tissue repair, given the potential of CD133 + cells in terms of plasticity, they might also participate in the progression or maintenance of pre-existing lesions [7, 16] . In the pulmonary circulation, this hypothesis is supported by a recent study in COPD showing an increased number of CD133 + cells infiltrating the hyperplasic intima of pulmonary arteries (PA), very close to denuded areas of endothelium [17] . In that study, the number of progenitor cells attached to the endothelium correlated with the thickness of the arterial wall, suggesting a potential association with the severity of the remodeling process. A potential link between systemic inflammation and circulating progenitors has also been suggested in COPD [18] .
We hypothesized that CD133 + cells possess ability to differentiate into smooth muscle cells (SMC) in the intima of pulmonary arteries, hence potentially contributing to initiate and/or perpetuate vessel remodeling. Accordingly, the aim of this study was to investigate the plasticity of human hematopoietic CD133 + cells to differentiate in vitro into both pulmonary atery smooth muscle cells (PASMC) and pulmonary artery endothelial cells (PAEC). In a second set of experiments, we evaluated the potential of CD133 + cells to migrate into the intima and differentiate into SMC incubating CD133 + cells into the lumen of human explanted PA. Finally, we explored the mechanisms, fusion or transdifferentiation, by which CD133 + cells may acquire the phenotype of tissue cells in human PA.
Materials and methods

Cell primary cultures and characterization
The human hematopoietic progenitor cell line CD133 + was obtained from Cambrex Bio Science (Walkersville, MD). Before using, CD133 + cells were expanded for 10 days in flasks at a density of 1 × 10 5 cells/mL in stem span medium supplemented with Flt-3ligand (100 ng/ml), StemCell factor (100 ng/ml) and Thrombopoietin (100 ng/ml) (Stem Cell Technologies, Vancouver, Canada) at 37°C in 5% CO 2 .
The PAEC line was purchased from American Type Culture Collection (HPAE-26, ATCC, Manassas, VA). Cells were cultured in endothelial cell growth medium (ECGM) composed of F-12K nutrient mixture (GIBCO BRL, Grand Island, NY) supplemented with 10% FBS, penicillin/ streptomycin (100 U/ml), heparin (0.1 mg/ml) and endothelial cell growth factor (0.03 mg/ml).
The PASMC line was obtained from Cambrex Bio Science. Cells were cultured in smooth muscle cell growth medium (SMCGM) composed of SMC basal medium (Clonetics, Cambrex) supplemented with 5% FBS, insulin, human fibroblast growth factor (hFGF-B), gentamicin/amphotericin-B and human epidermal growth factor (hEGF) (SmGM-2 SingleQuots, Clonetics, Cambrex).
After expansion, the hematopoietic progenitor cell phenotype was assessed by flow cytometry for the expression of CD133 and by immunofluorescence for the expression of CD45, CD133, CD34, CD31, VEGF2, vWF and vimentin markers and by RT-PCR.
The phenotype of PAEC was characterized by the LDLuptake, affinity to Ulex europaeus agglutinin I (UEA), and by the positive or negative expression of vimentin, vWF, CD34, CD133, CD45 and α-actin. The expression of genes related with the endothelial linage, CD34, vWF, vimentin, and eNOS were also determined by RT-PCR.
The phenotype of PASMC was characterized morphologically and by the immunoreactivity to antibodies against smooth muscle α-actin, and desmin. The expression of genes related with SMC, SMC α-actin and the potassium channels Kv1.5 and BKCa were also determined by RT-PCR.
Further details regarding material and methods can be found in the online supplementary material.
Labeling of CD133 + cells
For all co-culture experiments with PAEC and PASMC and with explanted PA, human CD133 + cells were previously labeled with 10 μg/ml 1,1′dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine-labeled acetylated LDL (Di1-acLDL; Molecular Probes, Invitrogen, Eugene, OR) for 3 h at 37°C, followed by 3 washes with PBS. The nontransferable dye Dil-acLDL was used for live monitoring of the human CD133 + cells during co-cultivation.
Co-culture experiments
For co-culture experiments, PAEC or PASMC were cultured in 24-well fibronectin plates (BD Biosciences, San Jose, CA) in ECGM and SMCGM respectively. After 48 h of culture, Dil-acLDL CD133 + cells were added at a density of 4 × 10 4 cells/well allowing them to differentiate. After 6 and 12 days, co-cultures were fixed in 4% paraformaldehyde and stained for UEA or SMC α-actin. At least 5 independent experiments were performed at each experimental condition. Control experiments for the effect of media on differentiation of Dil-acLDL CD133 + cells included co-cultures with PAEC in SMCGM and co-cultures with PASMC in ECGM.
In a second set of experiments, co-cultures were performed using a device (Nunc, Nalge Nunc International, Roskilde, Denmark) that maintained both cell lines separated by a membrane (pore size 0.2 μm) that allows the transit of molecules but not cells. Mature cells, PAEC or PASMC, were cultured in 24-well fibronectin plates for 6 and 12 days as previously described. Labeled progenitor cells were put into device chambers and then inserted inside wells containing mature cells.
Characterization of differentiated CD133
+ cells in co-cultures Co-cultures of PAEC with Dil-acLDL-labeled CD133 + cells were incubated with FITC-labeled UEA (Sigma-Aldrich) overnight at 4°C in the dark and examined under fluorescence microscope. Cells positive for both FITC-UEA and Dil-acLDL were judged to be endothelial cells which have differentiated from CD133 + cell. These co-cultures were also incubated with primary antibodies against CD31, vWF and CD34.
To evaluate the differentiation of CD133 + cells into smooth muscle cells, the co-culture of PASMC with DilacLDL-labeled CD133 + cells was assessed for the expression of α-smooth muscle actin and desmin. Also theses cocultures were assessed for negativity for CD31 and UEA.
Differentiation of Dil-acLDL labeled cells was quantified by flow cytometry and under fluorescence microscope. For flow cytometric analysis, the percentage of double positive cells, and then UEA + /Dil-acLDL-labelled cells, in both types of co-cultures was determined with a FACSCalibur flow 
Cultures of explanted PA with CD133 + cells
Intralobar pulmonary arteries (1 to 1.5 mm diameter) were dissected from human lungs (n = 5), obtained at lung resection for bronchogenic carcinoma. From each lung specimen, two 3 cm-long segments of PA were isolated under microscope in a laminar flow hood and cultured in ECGM for 3 h at 37°C in 5% CO 2 . Then, Dil-acLDL labeled CD133 + cells were injected using a 2 ml syringe with a 19G needle into the arterial lumen. The ends of arteries remained opened in order to improve gas exchange. The artery with CD133 + cells inside was left in ECGM at 37°C in 5% CO 2 for 2 and 4 days. Five independent experiments were + cells (red) after 12 days of co-culture with PASMC (e). Co-cultures were immunostained with a monoclonal antibody against SMC α-actin (green), which is specific for SMC (f). In blue, nuclei were counterstained with DAPI (g). Merged images (h). Scale bar, 20 μm.
performed. The endothelium of PA was dissected as previously described [17] . Some segments of arteries were fixed in 4% paraformaldehyde, cryoembedded in O.C.T and frozen at − 80°C for immunofluorescence analysis; the remaining ones were fixed with 2% paraformaldehyde and 2.5% glutaraldehyde for transmission electron microscopy (TEM).
Differentiation of CD133 + cells over the endothelial surface was characterized morphologically and by immunofluorescence using antibodies against vimentin, CD31, and CD34. Differentiation of CD133 + cells in the intima was assessed on cryostat sections of artery rings immunostained with an antibody against human α-SMC actin and by TEM. Under TEM, progenitors cells were identified by the content of LDL into the cytosol, since LDL particles can be seen as homogenous and dense vesicles.
Studies in human lung specimens had been approved by the Institutional Review Board and written informed consent was obtained from the patients before surgery.
Fluorescence in situ hybridization
Fluorescence in situ hybridization (FISH) for chromosome X and 15 were used to detect fusioned nuclei in harvested endothelia from pulmonary arteries (n = 5). We used commercially available probes labeled with FITC to detect the number of chromosomes X or 15 (Q-biogen Inc, Vista, CA) in interphase nuclei. Paraformaldehyde-fixed endothelia were mounted on poly-L-lysine treated slides. Nuclei with two or more dots were counted in 5 randomly areas and expressed as percentage of total nuclei.
RT-PCR
Total RNA was extracted from culture cells using a commercially available kit (Trizol Reagent; Life Technologies, GIBCO BRL; Carlsbad, CA).
Immunohistochemistry
For intercellular proteins, cells were permeabilized with 0.5% Triton X-100 for 30 min except when Dil-AcLDL was used. After blocking with non immune serum for 1 h, we used the following primary mouse monoclonal antibodies: CD45 (1:750 dilution; Novocastra Laboratories Ltd., Burlingame, CA), CD133 (1:10 Miltenyi Biotech, Bergisch Gladbach, Germany), Vimentin (1:1000 dilution; DAKO Cytomation, Carpinteria, CA), CD34 (1:150 dilution; Novocastra Laboratories Ltd), CD31 (1:200 dilution; DAKO Cytomation), VEGFR2 (1:200 dilution; Santa Cruz 
Results
In vitro differentiation of CD133 + cells
After 12 days of culture, CD133 + cells cultured alone in ECGM (Fig. 1) showed low affinity for the specific endothelial cell marker UEA, although they did not acquire morphology of PAEC. Supplementation with vascular endothelial growth factor (VEGF) or with a cocktail of cytokines improved the signal intensity for UEA, although the size and shape of the cells remained different from mature PAEC (Fig. 1) . No differentiation of CD133 + cells into SMC was observed when they were cultured alone with SMCGM. 
Co-culture of CD133
+ cells with PAEC and PASMC After 6 days of co-culture with PAEC, many Dil-acLDL labeled cells had integrated with them. These labeled cells displayed significant increases of their cell length and surface area, similar to adjacent mature cells (Fig. 2A) . More than 28% of total cells in co-culture were double positive for UEA and Dil-acLDL (about 85% of Dil-acLDL labeled cells) as revealed by FACs (Fig. 3) . Rounded mononuclear cells that remained undifferentiated were negative for UEA (data not show). Dil-acLDL labeled cells also differentiated in endothelial cells in this co-culture when they were incubated with SMCGM instead of ECGM.
As in co-cultures with PAEC, after 6 days of co-culture with PASMC, integrated Dil-acLDL labeled cells adopted a similar size and shape of adjacent mature cells. Under fluorescence microscope, Dil-acLDL labeled cells expressed SMC proteins such as specific SMC α-actin (Fig. 2B ) and desmin but not CD31 or affinity to UEA. The percentage of Dil-acLDL labeled cells showing α-actin organized filaments ranged between 8% and 9% of total SMC. Any Dil-acLDL-positive cells in this co-culture showed affinity to UEA neither at day 6 nor at day 12 ( Fig.  3 ) (see online supplementary material). Dil-acLDL labeled cells also differentiated in smooth muscle cells in this coculture when they were incubated with ECGM instead of SMCGM.
Co-cultures of human CD133
+ cells with mature cells separated by a trans-well membrane
In the double chamber devices, CD133 + cells acquired the phenotype of mature cells cultured in the other side of the membrane, and all cells showed affinity for UEA when cocultured with endothelial cells and α-actin when co-cultured with smooth muscle cells. The inverse stain was negative for both cultures. The morphology after 12 days was similar to that observed after 12 days when progenitors were cultured alone (Fig. 4) . 
Differentiation of CD133
+ cells in explanted pulmonary arteries Fig. 5A shows different sections of a PA incubated with Dil-acLDL labeled CD133 + cells. Two days after injecting CD133 + cells into the arterial lumen, a number of mononuclear cells were localized in the intima. The majority of them preserved the original morphology and remained close to the endothelial surface. After 4 days of co-incubation, cells acquired a more elongated morphology and the majority of them were localized in the intima towards the media.
Immunofluorescence studies performed on transverse sections revealed that some Dil-acLDL labeled cells confined into the intima were immunoreactive for smooth muscle α-actin indicating differentiation into SMC (Fig. 5B) . By contrast, Dil-acLDL-labeled cells adhered to the endothelium acquired an endothelial-like morphology and expressed the endothelial cell markers CD31 and vimentin (Fig. 5C) .
Sections of pulmonary arteries co-incubated with acLDLlabeled CD133 + cells were examined by electronic microscopy (Fig. 5D ). CD133 + cells were identified by the presence of large LDL vesicles in the cytosol. Some labeled cells, attached to the luminal surface, showed endothelial cell morphology; whereas cells located in the intima showed smooth muscle cell-like morphology. Some cells infiltrating the intima showed apparent dense bodies characteristic of smooth muscle cell filaments [19] . Interestingly, acLDLlabeled cells infiltrating the intima were preferentially localized close to denuded areas of endothelium.
Cell fusion evaluation
ImmunoFISH analysis revealed the presence of some scattered polyploid nuclei in pulmonary endothelia (Fig. 6A ) (see online supplementary material). The presence of tetraploid nuclei was not uniform over the extension analyzed. The number of fusioned nuclei ranged between 5 and 10% indicating that fusion was not a rare event. We also performed immunoFISH looking for polyploid nuclei on endothelial layers after incubation with Dil-acLDL labeled CD133 + cells, as described in the preceding section. In this case, we did not find fusioned nuclei within labeled CD133 + cells indicating that the mature phenotype was acquired by transdifferentiation (Fig. 6B) . Moreover, in electronic microscope studies we did not observe membrane fusions between progenitor and mature cells, further supporting the findings of in situ hybridization.
Discussion
In a previous study [17] we observed an increased number of CD133 + cells in PA of COPD patients. Positive cells were not only confined to the endothelial surface but also identified in the vessel wall, thus suggesting that these cells could play a role in pulmonary vessel remodeling. In this report, performed in vitro and in explanted human PA, we provide evidence of the plasticity of CD133 + cells to differentiate into both endothelial and smooth muscle cells.
The differentiation process of bone-marrow derived vascular progenitor cells was mimicked with the simplest scenario found in the arterial wall by co-culturing adult human PASMC or PAEC with CD133 + cells. In these experiments, the fate of CD133 + cells was conditioned by the type of mature cell they were co-cultured with, evidencing the plasticity of CD133 + . Evidence of the multipotentiality of CD133 + cells has been previously provided by Torrente and co-workers [14] who demonstrated their differentiation into skeletal muscle cells when co-cultured in the presence of a feeder layer of myogenic cells.
Presumably, mature cells in co-culture may act as a source of cytokines and growth factors that modulate the differentiation process. This was deduced from co-cultures of progenitor and mature cells, separated by a trans-well membrane (pore size 0.2 μm). In this setting, CD133
+ cells acquired markers of mature cell when they were incubated separately from PAEC or PASMC. Yet, these factors were insufficient to induce morphological changes, hence showing the crucial role of cell-to-cell contact for morphology acquisition. At present, we have not identified the molecules, namely growth factors and cytokines, which may participate in the mechanisms of differentiation in vitro or in vivo. Previous studies have shown that common vascular progenitor cells may give rise to endothelial cells in vitro upon exposure to supplemental VEGF [13, 20, 21] , and to SMCs when treated with platelet derived growth factor-BB (PDGF-BB) [22] . In these experiments, the formation of early outgrowth endothelial colonies is produced after 8-9 days of incubation whereas in our studies, full cell differentiation was already apparent at day 6 of co-culture. In this respect, we also observed that isolated CD133 + cells incubated with a supplement of VEGF differentiated into endothelial-like cells after 12 days. We observed a better signal intensity for endothelial cell markers when cells were incubated with a cocktail of cytokines, suggesting that complementary costimulation with other growth factors, a condition closer to the physiological environment, may accelerate the effect of VEGF on endothelial differentiation.
After checking in vitro the capability of CD133 + cells to differentiate into both endothelial and smooth muscle cell types, we aimed to explore the dynamics of spontaneous cell differentiation in co-cultures of human CD133 + injected into the lumen of explanted human PA. In this setting, mature cells of the endothelium or the intima might provide the micro-environment that could be crucial in determining the fate of CD133 + cells. Initially we selected a PA from a patient with severe COPD. That PA showed a prominent intima and denudated endothelium. When progenitor cells were co-incubated with the PA, we expected to find many progenitor cells repopulating the endothelium. However, a number of CD133 + cells migrated through the intima towards the media (Fig. 5A) . During the 4 days of coincubation, a gradual change in morphology from round to large and flat shape was observed in labeled cells, indicating that progenitor cells undergo trans-differentiation into smooth muscle-like cells. This was further supported by the identification of SMC α-actin expression. Furthermore, electron microscope analysis revealed a few progenitor cells, identified by the presence of LDL vesicles in the cytoplasm, fully integrated within cells of the media. All together, these results show that CD133 + cells are capable to migrate from the lumen into the intima and differentiate into SMC, at least in remodeled PA from COPD. We also incubated progenitor cells with PA with a more preserved endothelium. Interestingly, in these cases only few cells migrated into the intima. CD133 + cells integrated within the endothelium acquired endothelial cell morphology (Fig. 5D ). In the other hand, cells that migrated into the intima were close to endothelial fenestrations indicating that CD133 + cells might have reached the intima through these areas and that endothelium may operate in two ways, releasing local mediators for cell differentiation and as a physical barrier to cell migration towards the intima. In these respect, our experiments confirm that endothelial cell damage or endothelial denudation is crucial for the progression of pulmonary vascular remodeling in COPD [17, 23] . This observation is in line with evidences showing that contribution of recruited hematopoietic stem cells to vascular remodeling is strongly enhanced by tissue injury [24] [25] [26] .
It has been demonstrated that adult bone marrow cells in culture can be driven to differentiate into many different cell types, including hepatocytes, cardiomyocytes, skeletal muscle and neurons. However, there has been considerable controversy regarding their contribution to non-hematopoietic tissues in vivo. In fact, adult bone marrow cells might not be able to transdifferentiate autonomously, but instead this might depend on cell fusion to achieve the differentiated state [27, 28] . We also wondered whether circulating CD133 + cells can regenerate tissues in vivo by fusion with differentiated cells or if they might differentiate into mature cells without cell contact with other mature cells. For this reason, we first screened pulmonary endothelium for polyploid nuclei in order to check whether fusioned cells might arise spontaneously in normal tissue. In situ hybridization revealed the presence of scattered polyploid nuclei (Fig. 6A ) in PA endothelium, indicating that fusion is not a rare event in endothelial cells. However, cell fusion appears to be restricted to mature cells since in co-cultures or when progenitors were co-incubated with explanted PA we did not observe the intermediate formation of multi-nucleated cells (Figs. 5C and 6B). Moreover, in PA, some progenitor cells differentiated alone, without apparent contact with other cells. Despite we have not found multinucleated cells during differentiation of progenitors, we cannot rule out the possibility that in vivo the two processes may occur together. In either case, the mature cell seems to provide a direction or orientation that is necessary to restore the injured tissue.
In summary, our data demonstrate that CD133 + cells are capable of committing themselves to more than one lineage given the right environmental cues. This means that CD133 + cells lying in the luminal surface of pulmonary arteries can differentiate into endothelial cells or they can migrate into the intima and differentiate into smooth muscle cells. In pulmonary arteries, growth factors embedded in the extracellular matrix and/or the contact with resident cells might exert a strong signal to cell differentiation into smooth muscle cell or endothelial cell. Such differentiation seems to be conducted without evidence of cell fusion. Exploration of the growth factors and adhesion molecules that underlie the linkage between CD133 + differentiation and intimal thickening in injured arteries is important to better understand the mechanisms of vascular repair and, perhaps, may lead to novel approaches for the prevention of vascular remodeling.
